Exploring Disease-Modifying Treatments for Lewy-Body Dementia (Frontiers in Neuroscience)

Summary

The authors of this review remind readers that there are currently no disease-modifying therapies for Dementia with Lewy bodies (DLB). DLB accounts for perhaps 25% of all dementia cases.

This review covers therapeutic directions which have been explored for the treatment of DLB. Approaches, so far, have involved investigating the therapeutic potential of (i) strategies to decrease the level of alpha-synuclein, (ii) strategies to prevent cell-to-cell transmission of misfolded alpha-synuclein, and (iii) brain stimulation for DLB.

Full Text Link

Reference

Zhang, Q. Kim, YC. [and] Narayanan, NS. (2015). Disease-modifying therapeutic directions for Lewy-Body dementias. Frontiers in Neuroscience. August 20th 2015, Vol.9, 293. (Click here to view the PubMed abstract).

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, Quick Insights, Systematic Reviews and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.